{"id":624455,"title":"Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T01:49:47.494000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/bioavailability-bioequivalence/conduct-analysis-comparative.html","snippet":"Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies (PDF Version - 634 KB) Date Adopted: 2012/02/08 Revised Date: 2023/01/30 Effective Date: 2018/09/01 (for submissions filed on or after September 1, 2018) Please refer to the Notice to stakeholders –…","rawSnapshotUrl":"/api/snapshots/raw/624455","browseUrl":"https://replay.healtharchive.ca/job-6/20260227014947/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/bioavailability-bioequivalence/conduct-analysis-comparative.html#ha_snapshot=624455","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}